Replimune REPL
NASDAQ REPL
$15.01 -0.28 (-1.83%)
As of: Sep 4, 2026 · 2:29 PM EDT

Replimune (REPL) Profit After Tax (2017 - 2026)

Replimune (REPL) posted Profit After Tax of -$73.2 million for Q1 2026, down 3.3% sequentially from -$70.9 million in Q4 2025, and up 1.2% YoY from -$72.4 million in Q1 2025.

Analysis

Replimune (REPL) Profit After Tax (2017 - 2026) Analysis & Trends

Replimune has reported Profit After Tax for 10 years, with the latest figure at -$73.2 million in Q1 2026.

  • Quarterly Profit After Tax rose 1.2% year-over-year to -$73.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$313.9 million (down 26.96% YoY) and the FY2026 annual result came in at -$313.9 million, down 26.95% from the prior year.
  • Profit After Tax fell to -$73.2 million in Q1 2026 per REPL's latest filing, from -$70.9 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$31.7 million in Q1 2022 and troughed at -$86.7 million in Q2 2025.
  • A 5-year average of -$57.8 million and a median of -$53.8 million in 2024 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2024 and 2025: Profit After Tax grew 11.64% in 2024, then tumbled 61.22% in 2025.
  • Over 5 years, Profit After Tax stood at -$39.7 million in 2022, then dropped by 28.72% to -$51.1 million in 2023, then slipped by 29.75% to -$66.3 million in 2024, then declined by 6.94% to -$70.9 million in 2025, then decreased by 3.3% to -$73.2 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$73.2 million, -$70.9 million, and -$83.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -644.37 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 81.49 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -16.62 Mn
10 Replimune 1.45 Bn 1.45 Bn - -69.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -69.80 Mn
Mar 31, 2026 -73.77 Mn
Dec 31, 2025 -70.93 Mn
Sep 30, 2025 -83.10 Mn
Jun 30, 2025 -87.90 Mn
Mar 31, 2025 -74.10 Mn
Dec 31, 2024 -66.34 Mn
Sep 30, 2024 -53.06 Mn
Jun 30, 2024 -53.77 Mn
Mar 31, 2024 -55.08 Mn
Dec 31, 2023 -51.12 Mn
Sep 30, 2023 -60.04 Mn
Jun 30, 2023 -49.56 Mn
Mar 31, 2023 -49.26 Mn
Dec 31, 2022 -39.70 Mn
Sep 30, 2022 -43.10 Mn
Jun 30, 2022 -42.25 Mn
Mar 31, 2022 -31.70 Mn
Dec 31, 2021 -29.86 Mn
Sep 30, 2021 -29.36 Mn